Fertility Preservation Options for Cancer Patients Discussed at Renown Cancer Center

St. Paul, MN, October 22, 2014 --(PR.com)-- Renown Cancer Institute in Reno, NV was the setting for a presentation designed to promote education and extend access to fertility preservation services.

ReproTech, Ltd., a cryobank specializing in long-term storage of human reproductive tissue (sperm, eggs, embryos and ovarian and testicular tissue), and Walgreens, were invited to speak on the topic of fertility preservation for oncology patients.

ReproTech Site Director, Danika Batastini, along with Sheryl Lipari, L.P.N Clinical Education Specialist, addressed the oncology professionals at the Renown Institute for Cancer in an ongoing effort to provide education on fertility preservation options for cancer patients such as sperm banking, embryo and egg freezing and ovarian and testicular tissue freezing. ReproTech’s goal is to educate, as well as to increase communications and collaboration between members of oncology healthcare teams.

According to the American Cancer Society, 140,000 American men and women under 45 are newly diagnosed with cancer each year. Once diagnosed, there is a small window of time for them to preserve their fertility; therefore, access to cryopreservation services is extremely important. ReproTech, Ltd. has organized its Fertility Preservation Network to educate oncology professionals and caretakers, as well as provide much needed cryopreservation services. The network now includes members in 36 states and the Caribbean. Additionally, the work of organizations such as LIVESTRONG has advanced the awareness of the need for Fertility Preservation among the oncology community.

About ReproTech, Ltd.

ReproTech, Ltd. was founded in 1990 for the purpose of providing long-term cryostorage services and operates cryostorage facilities in Florida, Minnesota, Nevada and Texas. More information on ReproTech, Ltd. is available at reprotech.com or 888-489-8944. Information specific to the Fertility Preservation Network and its members can be found at fertilitypreservation.com.

About Walgreen & Ferring’s Heart Beat Program

For patients pursuing fertility preservation services prior to cancer treatment, Ferring Pharmaceuticals and Walgreens Specialty Pharmacy have developed the Heart Beat program to help ease some of the financial burden. The Heart Beat program offers eligible patients select fertility medications at no cost. More information on the Heart Beat program can be found at ferringfertility.com/savings/heartbeat .
ReproTech, Ltd.
Courtney Dennewitz